Cargando…
Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C
BACKGROUND: In January 2015, the first interferon-free direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection was approved for inclusion in Israel’s national basket of health services. During 2015, HCV genotype 1 patients with advanced liver fibrosis (stage F3-F4) were e...
Autores principales: | Avisar, Nitzan, Heller, Yael, Weil, Clara, Ben-Baruch, Aviva, Potesman-Yona, Shani, Oren, Ran, Chodick, Gabriel, Shalev, Varda, Ash, Nachman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618729/ https://www.ncbi.nlm.nih.gov/pubmed/28954630 http://dx.doi.org/10.1186/s13584-017-0172-1 |
Ejemplares similares
-
Burden of Endometriosis: Infertility, Comorbidities, and Healthcare Resource Utilization
por: Eisenberg, Vered H., et al.
Publicado: (2022) -
Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study
por: Chodick, Gabriel, et al.
Publicado: (2020) -
Cutaneous Comorbidities Associated With Atopic Dermatitis in Israel: A Retrospective Real-World Data Analysis
por: Leshem, Yael A., et al.
Publicado: (2022) -
Secular trends in testosterone- findings from a large state-mandate care provider
por: Chodick, Gabriel, et al.
Publicado: (2020) -
Correction to: Epidemiology and Economic Burden of Atopic Dermatitis: Real-World Retrospective Data from a Large Nationwide Israeli Healthcare Provider Database
por: Weil, Clara, et al.
Publicado: (2022)